Paratus Diagnostics

Paratus Diagnostics is a biotechnology and healthcare company, founded in 2012, that is making strides in the field of molecular testing and revolutionizing point-of-care diagnostics. Operating as a high-complexity CLIA certified lab, it offers critical and time-sensitive diagnostic testing solutions to healthcare providers and patients across the United States. One of its core advantages lies in developing accurate, efficient, and patient-friendly salivary tests. In addition to its clinical lab in Central Texas, it is also developing point-of-care diagnostic devices that deliver lab-quality results with convenience and precision, bringing together diverse technologies from molecular biology to systems processing. The company received a significant $5.21M Venture Round investment on 16 November 2018, showcasing the confidence investors have in its technological advancements and business model. With its focus on improving diagnostic technology, Paratus Diagnostics is well-positioned to make a significant impact in the healthcare industry, providing quality, timely, and cost-effective solutions to meet the needs of both healthcare providers and patients.